IMPROVED CEREBRAL MICROBLEED DETECTION IN MAGNETIC RESONANCE IMAGES USING A MULTI-SCALE 3D CONVOLUTIONAL NEURAL NETWORK (ID 1074)

Presentation Topic
AS35 TECHNOLOGY INNOVATIONS: ROBOTS, VIRTUAL REALITY, ARTIFICIAL INTELLIGENCE AND MORE
Е-Poster Audio MP3
My link to connect
https://imperial-ac-uk.zoom.us/j/96359339172?pwd=Uk9HMC9wZy9pbzc2MUVWdk9OUW1EUT09
Availability
Sep 2, 2021 12:00 -13:00 GMT (Can be flexible if needed)

Abstract

Background And Aims

Cerebral microbleeds are an important neuroimaging biomarker for haemorrhage risk. Their utility in clinical practice is limited as manual detection from magnetic resonance images can be time-consuming and error-prone. Despite recent advances, automated detection remains a challenging task due to their small size, widespread distribution, and frequency of mimics such as veins and calcifications. This study aims to address these obstacles by developing and validating a fully automated approach utilising information at multiple scales to better detect cerebral microbleeds.

Methods

An efficient two-stage approach was developed: first, using a traditional three-dimensional radial symmetry transform stage to detect candidates; and second, using a novel three-dimensional convolutional neural network (3D-CNN) stage to reduce false positives. Compared with previous methods, our 3D-CNN incorporates larger contextual information by employing a dual pathway residual architecture that processes candidates at multiple scales simultaneously. The proposed approach was trained and evaluated using a recently released public dataset consisting of susceptibility-weighted imaging data for 780 microbleeds from 72 subjects with high and 107 subjects with low in-plane resolution.

Results

An overall 5-fold cross-validated sensitivity of 87.7% and 72.2% were achieved with an average of 1.33 and 1.79 false positives per subject for the high and low in-plane resolution data respectively.

Conclusions

The developed approach outperformed existing methods on the public dataset with comparable sensitivity but fewer false positives. It is hoped that this work will help reduce the burden of measuring microbleeds and facilitate better risk scores.

Trial Registration Number

Not applicable

Hide

Availability

Sep 2, 2021 12:00 -13:00 GMT (Can be flexible if needed)
Hide

Е-Poster Audio MP3

Hide